Friday, July 10, 2015

Boston land of death in many two forms


1. Pressure cooker kid a man of action, reprehensible
2 Peter slavin , a man who has done nothing to se that Bcg is easily available to all in need in Boston, the state of ma and the united states.


Bostonians with autoimmune diseases are being physically degraded by the lack of availability
Of Bcg in Boston.

Bcg works well. I am looking for help in documenting same on you tube.

Many people will die and be needlessly degraded while faustman dances with the FDA


Shoot Bcg and live better















  • Contact - Clark+Elbing

    www.clarkelbing.com/contact.php
    Contact. Clark+Elbing LLP 101 Federal Street, 15th Floor Boston, MA 02110- 1800. T: 617-428-0200. F: 617-428-7045 info@clarkelbing.com. If you would like to ...





    • Peter L. Slavin, MDPeter L. Slavin, MD
    President, Massachusetts General Hospital
    Peter L. Slavin, MD, has been the president of Massachusetts General Hospital since 2003. From 1999–2002, he served as chairman and chief executive officer of the Massachusetts General Physicians Organization, which included more than 1,700 physicians and employed nearly 1,000 of them.
    From 1997–1999, Dr. Slavin served as president of Barnes-Jewish Hospital in St. Louis, MO. Before that, he did his training in internal medicine at Mass General from 1984–1987 and was senior vice president and chief medical officer from 1994–1997.
    Dr. Slavin graduated from Harvard College in 1979, Harvard Medical School in 1984 and Harvard Business School in 1990.
    Dr. Slavin teaches internal medicine and health care management at Harvard Medical School, where he is a professor of health care policy. He lectures widely on topics including quality and utilization management, the economics of teaching hospitals and the state of physician practices.







    Todd Armstrong - Clark+Elbing

    United States Patent8,697,077
    FaustmanApril 15, 2014
    Methods and compositions for treating autoimmune diseases 


    Abstract
    The invention features methods for increasing or maintaining the number of functional cells of a predetermined type, for example, insulin producing cells of the pancreas, blood cells, spleen cells, brain cells, heart cells, vascular tissue cells, cells of the bile duct, or skin cells, in a mammal (e.g., a human patient) that has injured or damaged cells of the predetermined type.
    Inventors:Faustman; Denise L. (Boston, MA)
    Applicant:
    NameCityStateCountryType

    Faustman; Denise L.
    Boston
    MA
    US
    Assignee:The General Hospital Corporation (Boston, MA) 
    Family ID:30002891
    Appl. No.:13/462,160
    Filed:May 2, 2012
    Prior Publication Data
    Document IdentifierPublication Date
    US 20120213731 A1Aug 23, 2012
    Related U.S. Patent Documents

    Application NumberFiling DatePatent NumberIssue Date
    12632452Dec 7, 20098173129
    10358664Feb 5, 20037628988
    60392687Jun 27, 2002
    Current U.S. Class:424/139.1; 424/142.1; 424/154.1; 424/577
    Current CPC Class:A61K 35/26 (20130101); A61K 39/04 (20130101); A61K 35/39 (20130101); A61K 35/44 (20130101); A61K 38/1866 (20130101); A61K 38/191 (20130101); A61K 35/28 (20130101); A61K 35/30 (20130101); A61K 38/1774 (20130101); A61K 35/28 (20130101); A61K 35/44 (20130101); A61K 38/191 (20130101); A61K 38/1866 (20130101); A61K 35/39 (20130101); A61K 35/26 (20130101); A61K 38/1774 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101); A61K 2300/00 (20130101)
    Current International Class:A61K 35/26 (20060101); A61K 35/28 (20060101); A61K 39/40 (20060101); A61K 39/395 (20060101)
    References Cited [Referenced By]
    U.S. Patent Documents
    4309418January 1982Green
    4457916July 1984Hayashi et al.
    4495282January 1985Ohnishi et al.
    4677063June 1987Mark et al.
    4677064June 1987Mark et al.
    4681760July 1987Fathman
    4791101December 1988Adolf
    4816567March 1989Cabilly et al.
    4879226November 1989Wallace et al.
    4963354October 1990Shepard et al.
    4985241January 1991Zimmerman et al.
    5002876March 1991Sreekrishna et al.
    5059530October 1991Oshima et al.
    5139481August 1992Faustman et al.
    5215743June 1993Singh et al.
    5283058February 1994Faustman
    5288852February 1994Yamada et al.
    5370870December 1994Wong
    5487984January 1996Allet et al.
    5538854July 1996Faustman
    5560908October 1996Satoh et al.
    5593698January 1997Weiner et al.
    5783216July 1998Faustman
    5821337October 1998Carter et al.
    5843425December 1998Sachs et al.
    5843452December 1998Wiedmann et al.
    5874306February 1999Beattie et al.
    5919452July 1999Le et al.
    6046031April 2000Ni et al.
    6056952May 2000Rosenberg
    6159461December 2000Besmer et al.
    6165737December 2000Wang et al.
    6284879September 2001Faustman
    6414218July 2002Faustman et al.
    6420139July 2002Classen
    6491908December 2002Rosenberg
    6599710July 2003Faustman
    6617171September 2003Faustman et al.
    6660487December 2003Faustman
    6773705August 2004Faustman et al.
    6844011January 2005Faustman
    6866843March 2005Habener et al.
    6923959August 2005Habener et al.
    6984380January 2006Faustman
    7015037March 2006Furcht et al.
    7438902October 2008Habener et al.
    7485293February 2009Faustman
    7510877March 2009Yilmaz et al.
    7537756May 2009Habener et al.
    7582313September 2009Faustman
    7628988December 2009Faustman
    8173129May 2012Faustman
    2002/0106689August 2002Faustman et al.
    2002/0123472September 2002Faustman
    2002/0187548December 2002Keller et al.
    2003/0005469January 2003Faustman et al.
    2003/0031657February 2003Habener et al.
    2004/0028658February 2004Faustman
    2004/0031066February 2004Faustman et al.
    2004/0229785November 2004Faustman
    2005/0158288July 2005Faustman
    2005/0158302July 2005Faustman et al.
    2005/0244386November 2005Habener et al.
    2006/0062769March 2006Habener et al.
    2007/0116688May 2007Faustman
    2008/0102054May 2008Faustman
    2010/0068177March 2010Faustman
    Foreign Patent Documents
    WO-92/04033Mar 1992WO
    WO-95/24914Sep 1995WO
    WO-95/25533Sep 1995WO
    WO-97/08328Mar 1997WO
    WO-97/21802Jun 1997WO
    WO-00/53209Sep 2000WO
    WO-02/26819Apr 2002WO
    WO-2004/003164Jan 2004WO
    Other References

    Kaufman et al., J of Immunol. 1997, V.158, pp. 2435-2442. cited by examiner .
    Feldman et al., Transplant. Proc. 1998, 30, 4126-4127. cited by examiner .
    Mestas et al J. of Immunology, 2004, 172, pp. 2731-238. cited by examiner .
    Corbett et al. (Proc Natl Acad Sci U S A. Mar. 1, 1993 ;90(5): 1731-5. cited by examiner .
    Couzin Science, 2006, V.311, p. 1694. cited by examiner .
    Fischer et al., "A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death," PloS One. 6(11):e27621(1-11) (2011). cited by applicant .
    Loetscher et al., "Human tumor necrosis factor .alpha. (TNF .alpha.) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors," J Biol Chem. 268(35):26350-26357 (1993). cited by applicant .
    Van Zee et al., "A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon," J Exp Med. 179(4):1185-1191 (1994). cited by applicant .
    Welborn et al., "A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon," J Exp Med. 184(1):165-171 (1996). cited by applicant .
    Creasey et al., "Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines," Cancer Res. 47(1):145-9 (1987). cited by applicant .
    Tavernier et al., "Analysis of the structure-function relationship of tumour necrosis factor. Human/mouse chimeric TNF proteins: general properties and epitope analysis," J Mol Biol. 21 1(2):493-501 (1990). cited by applicant .
    Al-Awquati et al., "Stem cells in the kidney," Kidney Int. 61:387-395 (2002). cited by applicant .
    Aldrich et al., "Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice," Proc Natl Acad Sci USA. 91:6525-6528 (1994). cited by applicant .
    Alison et al., "Hepatocytes from non-hepatic adult stem cells," Nature. 406:257 (2000). cited by applicant .
    Allen et al., "Effect of Bacillus calmette-guerin vaccination on new-onset Type 1 Diabetes," Diabetes Care. 22(1):1703-1707 (1999). cited by applicant .
    Altomonte et al., "Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity," Clin Rheumatol. 11(2):202-205 (1992). cited by applicant .
    Anderson et al., "The NOD mouse: A model of immune dysregulation," Annu Rev Immunol. 23:447-485 (2005). cited by applicant .
    Anderson et al., "Can stem cells cross lineage boundaries?," Nat Med. 7:393-395 (2001). cited by applicant .
    Anderson et al., "Studies on the cytophilic properties of human .beta.2 microglobulin," J Immunol. 114:997-1000 (1975). cited by applicant .
    Aristarkhov et al., " E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins," Proc Natl Acad Sci USA. 93:4294-4299 (1996). cited by applicant .
    Aranda et al., "Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T Cells to SCID recipients," J Immunol. 158(7):3464-3473 (1997). cited by applicant .
    Ashton-Rickardt et al., "Peptide contributes to the specificity of positive selection of CD8+ T Cells in the thymus," Cell. 73:1041-1049 (1993). cited by applicant .
    Ashton-Rickardt et al., "Evidence for a differential avidity model of T Cell selection in the thymus," Cell . 76:651-663 (1994). cited by applicant .
    Atkinson et al., "The NOD mouse model of Type 1 Diabetes: As good as it gets?," Nat Med. 5(6):601-604 (1999). cited by applicant .
    Baeuerle et al, "NF-kB: Ten years after," Cell. 87:13-20 (1996). cited by applicant .
    Baeza et al., "Pancreatic regenerating gene overexpression in the nonobese diabetic mouse during active diabetogensis," Diabetes. 45(1):67-70 (1996). cited by applicant .
    Baeza et al., "Reg protein: a potential beta-cell-specific growth factor?," Diabetes Metab. 22:229-234 (1996). cited by applicant .
    Baeza et al., "Specific reg II gene overexpression in the non-obese diabetic mouse pancreas during active diabetogenesis," FEBS Letters. 416:364-368 (1997). cited by applicant .
    Baik et al., "BCG vaccine prevents insulitis in low dose streptozotocin-induced diabetic mice," Diabetes Res. and Clin. Pract. 46: 91-97, 1999. cited by applicant .
    Baldwin, "The NF-.sub.kB and I.sub.kB proteins: new discoveries and insights," Ann. Rev. Immunol. 14:649-683 (1996). cited by applicant .
    Ban et al., "Selective death of autoreactive T Cells in human diabetes by TNF or TNF receptor 2 agonism," Proc. Natl. Acad. Sci. USA 105: 13644-13649, 2008. cited by applicant .
    Barres, "A new role for glia: generation of neurons!," Cell 97: 667-670, 1999. cited by applicant .
    Baxter et al., "Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice," Immunology. 83:227-231 (1994). cited by applicant .
    Beg et al., "An essential role for NF-KB in preventing TNF-.alpha.-induced cell death," Science. 274:782-784 (1996). cited by applicant .
    Bernabeu et al., ".beta.2 -microglobulin from serum associates with MHC class I antigens on the surface of cultured cells," Nature. 308:642-645 (1984). cited by applicant .
    Bendelac et al., "Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates," J. Exp. Med. 166:823-832 (1987). cited by applicant .
    Bill et al, "Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human disease," Arthritis Res. 4:261-265 (2002). cited by applicant .
    Bjornson et al., "Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vitro," Science. 283:534-537 (1999). cited by applicant .
    Boches et al, "Role for the adenosine triphosphate-dependent proteolytic pathway in reticulocyte maturation," Science. 215:978-980 (1982). cited by applicant .
    Bras et al., "Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease," Immunology. 89:20-25 (1996). cited by applicant .
    Brayer et al., "Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy, " J. Rheumatol. 27(8):1896-1904 (2000). cited by applicant .
    Brazelton et al., "From marrow to brain: expression of neuronal phenotypes in adult mice," Science. 290:1775-1779 (2000). cited by applicant .
    Brod et al., "Ingested interferon .alpha. suppresses Type I diabetes in non-obese diabetic mice," Diabetologia. 41:1227-1232 (1998). cited by applicant .
    Brodbeck et al., "Genetic determination of nephrogenesis: the pax/eya/six gene network," Pediatr. Nephrol. 19:249-255 (2004). (Abstract Only). cited by applicant .
    Bunting et al., "Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo," Blood. 96(3):902-909 (2000). cited by applicant .
    Cavallo et al., "BCG vaccine with and without nicotinamide in recent onset IDDM: a multicenter randomized trial," Autoimmunity 24(Suppl.1):A063 (1996). cited by applicant .
    Caetano et al., "Effect of methotrexate (MTX) on NAD(P)+ dehydrogenases of HeLa cells: malic enzyme, 2- oxoglutarate and isocitrate dehydrogenases," Cell Biochem Funct. 15(4):259-264 (1997). cited by applicant .
    Chatenoud et al., "CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice," J Immunol. 158(6):2947-2954 (1997). cited by applicant .
    Choi et al., "Prevention of Encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis Bacillus Calmette-Guerin in susceptible mice," Diabetes. 49:1459-1467 (2000). cited by applicant .
    Cole et al., "Two ParaHox genes, SpLox and SpCdx, interact to partition the posterior endoderm in the formation of a functional gut," Development. 136:541-549 (2009). cited by applicant .
    Colucci et al., "Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide," J Autoimmunity 9:271-276 (1996). cited by applicant .
    Corbett et al., "Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of langerhans" Proc Natl Acad Sci USA. 90(5):1731-1735 (1993). cited by applicant .
    Coux et al., "Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor .sub.KB1," J Biol Chem. 273(15):8820-8828 (1998). cited by applicant .
    Couzin, "Diabetes studies conflict on power of spleen cells," Science. 311:1694 (2006). cited by applicant .
    Darzynkiewicz et al., "Use of flow and laser scanning cytometry to study mechanisms regulating cell cycle and controlling cell death," Clinics in Laboratory Medicine. 21:857-873 (2001). cited by applicant .
    Dear et al., "The Hox11 gene is essential for cell survival during spleen development," Development. 121:2909-2915 (1995). cited by applicant .
    Declaration of Dr. Denise Faustman from U.S. Appl. No. 10/358,644, filed on May 15, 2009. cited by applicant .
    Dieguez-Acuna et al., "Characterization of mouse spleen cells by subtractive proteomics," Mol Cell Proteomics. 4(10):1459-1470 (2005). cited by applicant .
    Dieguez-Acuna et al., "Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen," Int J Biochem Cell Biol. 42:1651-1660 (2009). cited by applicant .
    Dilts et al., "Autoimmune diabetes: The involvement of benign and malignant autoimmunity," J Autoimmun. 12:229-232 (1999). cited by applicant .
    Dinarello, "Interleukin-1, Interleukin-1 receptors and Interleukin-1 receptor antagonist," Intern Rev Immunol. 16:457-499 (1998). cited by applicant .
    Driscoll et al., "The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins," J Biol Chem. 265:4789-4792 (1990). cited by applicant .
    Durand et al., "Mesenchymal lineage potentials of Aorta-Gonad-Mesonephros stromal clones," Heamatologica. 91:1172-1179 (2006). cited by applicant .
    Eglitis et al., "Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice," Proc Natl Acad Sci USA. 94:4080-4085 (1997). cited by applicant .
    Elliott et al., "Effect of Bacille Calmette-Guerin vaccination on C-Peptide secretion in children newly diagnosed with IDDM," Diabetes Care. 21(10):1691-1693 (1998). cited by applicant .
    Eytan et al., "ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin," Proc Natl Acad Sci USA. 86:7751-7755 (1989). cited by applicant .
    Fan et al., "Generation of p50 subunit of NF-KB by processing of p105 through an ATP-dependent pathway," Nature. 354:395-398 (1991). cited by applicant .
    Faustman et al., "Abnormal T-lymphocyte subsets in Type I Diabetes," Diabetes. 38:1462- 1468 (1989). cited by applicant .
    Faustman et al., "Linkage of faulty major histocompatibility complex class I to autoimmune diabetes," Science. 254:1756-1761 (1991). cited by applicant .
    Faustman et al., "Murine pancreatic .beta.-Cells express H-2K and H-2D but not la Antigens," J Exp Med. 151:1563-1568 (1980). cited by applicant .
    Faustman et al., "Prevention of xenograft rejection by masking donor HLA class I antigens," Science. 252:1700-1702 (1991). cited by applicant .
    Faustman et al., "T-lymphocyte changes linked to autoantibodies. Association of insulin autoantibodies with CD4+CD45R+ lymphocyte subpopulation in prediabetic subjects," Diabetes. 40:590-597 (1991). cited by applicant .
    Feldman et al., "Anti-TNF.alpha. therapy is useful in rheumatoid arthritis and Crohn's disease: Analysis of the mechanism of action predicts utility in other diseases," Transplant Proc. 30(8):4126-4127 (1998). cited by applicant .
    Ferrando et al., "Adult T-Cell ALL patients whose lymphoblasts express the HOX11 oncogene have an excellent prognosis when treated with chemotherapy and are not candidates for allogeneic bone marrow transplantation in first remission," Blood. 11:154A (2002). cited by applicant .
    Fischer et al., "An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity," J Immunol Methods. 259:159-169 (2002). cited by applicant .
    Foulis, "C.L. Oakley lecture (1987). The pathogenesis of beta cell destruction in Type I (insulin-dependent) diabetes mellitus," J Pathol. 152(3):141-148 (1987). cited by applicant .
    Fu et al., "Antigen processing and autoimmunity: Evaluation of mRNA abundance and function of HLA-Linked genes," Ann NY Acad Sci. 842:138-155 (1998). cited by applicant .
    Fu et al., "Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity," J Clin Invest. 91:2301-2307 (1993). cited by applicant .
    Fukada et al., "Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis," Immunity. 5:449-460 (1996). cited by applicant .
    Gage, "Mammalian neural stem cells," Science. 287:1433-1438 (2000). cited by applicant .
    Gage et al., "Multipotent progenitor cells in the adult dentate gyrus," J Neurobiol. 36:249-266 (1998). cited by applicant .
    Ganoth et al., "A multicomponent system that degrades proteins conjugated to ubiquitin. Resolution of factors and evidence for ATP-dependent complex formation," J Biol Chem. 263(25):12412-12419 (1988). cited by applicant .
    Gaur et al., "Induction of islet allotolerance in nonhuman primates," Ann NY Acad Sci. 958:199-203 (2002). cited by applicant .
    Gazda et al., "Diabetes results from a late change in the autoimmune response of NOD mice," J Autoimmun. 10:261-270 (1997). cited by applicant .
    Gazda et al., "Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies," Immunol Cell Biol. 74: 401-407 (1996). cited by applicant .
    Genestier et al., "Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T Cells," J Clin Invest. 102(2):322-328 (1998). cited by applicant .
    Gerich et al., "Advances in diabetes for the millenium: Understanding insulin resistance," MedGenMed. 6(Suppl): 11:1-9 (2004). cited by applicant .
    Ghosh et al., "Activation in vitro of NF-.sub.kB by phosphorylation of its inhibitor I.sub.kB," Nature. 344:678-682 (1990). cited by applicant .
    Glas et al., "The CD8+ T Cell repertoire in .beta.2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I," J Exp Med. 179(2):661-672 (1994). cited by applicant .
    Goldberg, "Functions of the proteasome: The lysis at the end of the tunnel," Science. 268:522-523 (1995). cited by applicant .
    Goldberg, "The mechanism and functions of ATP-dependent proteases in bacterial and animal cells," Eur J Biochem. 203:9-23 (1992). cited by applicant .
    Gottlieb et al., "Cell acidification in apoptosis: Granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H.sup.+-ATPase," Proc Natl Acad Sci USA. 92:5965-5968 (1995). cited by applicant .
    Graves et al., "Lack of association between early childhood immunizations and .beta.-Cell autoimmunity," Diabetes Care 22:1694-1967 (1999). cited by applicant .
    Grewal et al., "Local expression of transgene encoded TNF.alpha. in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T Cells," J Exp Med. 184:1963-1974 (1996). cited by applicant .
    Grilli et al., "Neuroprotection by aspirin and sodium salicylate through blockade of NF-kB activation," Science. 274:1383-1385 (1996). cited by applicant .
    Gronostajski et al., "The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts," J Biol Chem. 260(6):3344-3349 (1985). cited by applicant .
    Gueckel et al., "Mutations in the yeast proteasome B-Type subunit Pre3 uncover position-dependent effects on proteasomal peptidase activity and in vivo function," J Biol Chem. 273(31): 19443-19452 (1998). cited by applicant .
    Gupta, "Molecular steps of tumor necrosis factor receptor-mediated apoptosis," Curr Mol Med. 1(3):317-324 (2001). cited by applicant .
    Haas et al., "Pathways of ubiquitin conjugation," FASEB J. 11:1257-1268 (1997). cited by applicant .
    Hao et al., "Effect of mycophenolate mofetil on islet allografting to chemically induced or spontaneously diabetic animals," Transplant Proc. 24(6): 2843-2844 (1992). cited by applicant .
    Harada et al., "Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination," Diabetes Res Clin Pract. 8:85-89 (1990). cited by applicant .
    Hartwell et al., "Aberrant cytokine regulation in macrophages from young autoimmune-prone mice: Evidence that the intrinsic defect in MRL macrophage IL-1 expression is transcriptionally controlled," Mol Immunol. 32(10):743-751 (1995). cited by applicant .

    www.clarkelbing.com/professionals.php?p=armstrong
    Registered to practice before the U.S. Patent and Trademark Office Admitted to the bar in Massachusetts. Todd Armstrong has been at Clark+Elbing since 2001.


    Posted by at

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)